After the demonstration that the PI3K/AKT pathway is constitutively active in MM, providing signals that induce proliferation, angiogenesis, and development of drug resistance, several preclinical studies have shown that PI3K/AKT inhibition was able to induce tumor inhibition and regression in cell-line and animal models [48]. Here, AKT1 is linked to neoplasm.